ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,700.20
-5.00 (-0.29%)
Last Updated: 08:07:15
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -5.00 -0.29% 1,700.20 1,700.40 1,701.40 1,703.60 1,699.40 1,701.60 77,357 08:07:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.25 70.2B

GlaxoSmithKline PLC Director/PDMR Shareholding (3593X)

20/02/2017 3:55pm

UK Regulatory


Gsk (LSE:GSK)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Gsk Charts.

TIDMGSK

RNS Number : 3593X

GlaxoSmithKline PLC

20 February 2017

GlaxoSmithKline plc (the 'Company')

Shares withheld or sold to meet tax liabilities

Following the vesting of awards granted in 2014 under the GlaxoSmithKline 2009 Performance Share Plan on 16 February 2017 and as notified on 17 February 2017, the notifications that follow reflect changes in the interests of Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them ('PCA") in Ordinary Shares and in American Depositary Shares (ADSs) of the Company arising from the sale or withholding of Ordinary Shares or ADSs to meet tax liabilities. This notification also includes the sale further to the vesting of awards granted in 2012 to Sir Andrew Witty which were subject to an additional holding period.

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ======================================================================= 
 a)   Name                     Sir Andrew Witty 
===  ========================  ============================================= 
 b)   Position/status          Chief Executive Officer 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  ============================================= 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities for the vesting of awards 
                                granted in 2012 and 2014 under the Company's 
                                2009 Performance Share Plan. 
===  ========================  ============================================= 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s)                ------------  ---------- 
                                 GBP16.2437    9,057 
                                ------------  ---------- 
                                 GBP16.2437    166 
                                ------------  ---------- 
                                 GBP16.2437    55,441 
                                ------------  ---------- 
===  ========================  ============================================= 
 d)   Aggregated information    64,664 GBP16.2437 
       Aggregated volume 
       Price 
===  ========================  ============================================= 
 e)   Date of the transaction  2017-02-16 
===  ========================  ============================================= 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ===================================================================== 
 a)   Name                     Ms E Walmsley 
===  ========================  =========================================== 
 b)   Position/status          CEO Designate 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities for the vesting of awards 
                                granted in 2014 under the Company's 2009 
                                Performance Share Plan. 
===  ========================  =========================================== 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s)                ------------  ---------- 
                                 GBP16.2437    19,218 
                                ------------  ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ===================================================================== 
 a)   Name                     Mr R G Connor 
===  ========================  =========================================== 
 b)   Position/status          President, Global Manufacturing and Supply 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities for the vesting of awards 
                                granted in 2014 under the Company's 2009 
                                Performance Share Plan. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                 ------------  ---------- 
                                  GBP16.2437    14,957 
                                 ------------  ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ===================================================================== 
 a)   Name                     Mr S Dingemans 
===  ========================  =========================================== 
 b)   Position/status          Chief Financial Officer 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities for the vesting of awards 
                                granted in 2014 under the Company's 2009 
                                Performance Share Plan. 
===  ========================  =========================================== 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s)                ------------  ---------- 
                                 GBP16.2437    32,529 
                                ------------  ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================= 
 a)   Name                     Mr N Hirons 
===  ========================  =============================================== 
 b)   Position/status          SVP, Global Ethics & Compliance 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           GlaxoSmithKline plc American Depositary 
       the financial            Shares ('ADSs') 
       instrument               ISIN: US37733W1053 
===  ========================  =============================================== 
 b)   Nature of the            The withholding of ADSs to meet tax liabilities 
       transaction              further to the vesting of awards granted 
                                in 2014 under the Company's 2009 Performance 
                                Share Plan. 
===  ========================  =============================================== 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                 ---------  ---------- 
                                  $40.57     1,255 
                                 ---------  ---------- 
===  ========================  =============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =============================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =============================================== 
 f)   Place of the             n/a 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ===================================================================== 
 a)   Name                     Mr S A Hussain 
===  ========================  =========================================== 
 b)   Position/status          President, Global Pharmaceuticals 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities for the vesting of awards 
                                granted in 2014 under the Company's 2009 
                                Performance Share Plan. 
===  ========================  =========================================== 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s)                ------------  ---------- 
                                 GBP16.2437    27,371 
                                ------------  ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================= 
 a)   Name                     Mr B McNamara 
===  ========================  =============================================== 
 b)   Position/status          CEO, Consumer Healthcare 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           GlaxoSmithKline plc American Depositary 
       the financial            Shares ('ADSs') 
       instrument               ISIN: US37733W1053 
===  ========================  =============================================== 
 b)   Nature of the            The withholding of ADSs to meet tax liabilities 
       transaction              further to the vesting of awards granted 
                                in 2015 under the Company's 2009 Performance 
                                Share Plan. 
===  ========================  =============================================== 
 c)   Price(s) and              Price(s)   Volume(s) 
       volume(s)                ---------  ---------- 
                                 $40.57     10,082 
                                ---------  ---------- 
===  ========================  =============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =============================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =============================================== 
 f)   Place of the             n/a 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ===================================================================== 
 a)   Name                     Mr D S Redfern 
===  ========================  =========================================== 
 b)   Position/status          Chief Strategy Officer 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities for the vesting of awards 
                                granted in 2014 under the Company's 2009 
                                Performance Share Plan. 
===  ========================  =========================================== 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s)                ------------  ---------- 
                                 GBP16.2437    10,738 
                                ------------  ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ===================================================================== 
 a)   Name                     Ms C Thomas 
===  ========================  =========================================== 
 b)   Position/status          SVP, Human Resources 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities for the vesting of awards 
                                granted in 2014 under the Company's 2009 
                                Performance Share Plan. 
===  ========================  =========================================== 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s)                ------------  ---------- 
                                 GBP16.2437    15,320 
                                ------------  ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ===================================================================== 
 a)   Name                     Mr P C Thomson 
===  ========================  =========================================== 
 b)   Position/status          SVP, Communications & Government Affairs 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities for the vesting of awards 
                                granted in 2014 under the Company's 2009 
                                Performance Share Plan. 
===  ========================  =========================================== 
 c)   Price(s) and              Price(s)      Volume(s) 
       volume(s)                ------------  ---------- 
                                 GBP16.2437    7,307 
                                ------------  ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================= 
 a)   Name                     Mr D E Troy 
===  ========================  =============================================== 
 b)   Position/status          SVP & General Counsel 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           GlaxoSmithKline plc American Depositary 
       the financial            Shares ('ADSs') 
       instrument               ISIN: US37733W1053 
===  ========================  =============================================== 
 b)   Nature of the            The withholding of ADSs to meet tax liabilities 
       transaction              further to the vesting of awards granted 
                                in 2014 under the Company's 2009 Performance 
                                Share Plan. 
===  ========================  =============================================== 
 c)   Price(s) and              Price(s)   Volume(s) 
       volume(s)                ---------  ---------- 
                                 $40.57     13,035 
                                ---------  ---------- 
===  ========================  =============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =============================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =============================================== 
 f)   Place of the             n/a 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ===================================================================== 
 a)   Name                     Dr P J T Vallance 
===  ========================  =========================================== 
 b)   Position/status          President, R&D 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities for the vesting of awards 
                                granted in 2014 under the Company's 2009 
                                Performance Share Plan. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                 ------------  ---------- 
                                  GBP16.2437    32,996 
                                 ------------  ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ===================================================================== 
 a)   Name                     Mrs V A Whyte 
===  ========================  =========================================== 
 b)   Position/status          Company Secretary 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities for the vesting of awards 
                                granted in 2014 under the Company's 2009 
                                Performance Share Plan. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                 ------------  ---------- 
                                  GBP16.2437    2,197 
                                 ------------  ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================= 
 a)   Name                     Dr K Slaoui 
===  ========================  =============================================== 
 b)   Position/status          PCA of Dr M M Slaoui (Chairman, Global 
                                Vaccines) 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           GlaxoSmithKline plc American Depositary 
       the financial            Shares ('ADSs') 
       instrument               ISIN: US37733W1053 
===  ========================  =============================================== 
 b)   Nature of the            The withholding of ADSs to meet tax liabilities 
       transaction              further to the vesting of awards granted 
                                in 2014 under the Company's 2009 Performance 
                                Share Plan. 
===  ========================  =============================================== 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                 ---------  ---------- 
                                  $40.57     249 
                                 ---------  ---------- 
===  ========================  =============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =============================================== 
 e)   Date of the transaction  2017-02-16 
===  ========================  =============================================== 
 f)   Place of the             n/a 
       transaction 
===  ========================  =============================================== 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEBLFLDLFEBBE

(END) Dow Jones Newswires

February 20, 2017 10:55 ET (15:55 GMT)

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock